Dimerix signs up first patient for 'highly significant' paediatric clinical trial
Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric patient for the Phase 3 ACTION3 clinical trial in a major next step for the research.The trial will investigate the efficacy of DMX-200 in children aged 12 to 17 with focal seg...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MMH | Ann: Independent Director Determination | 13/12/24 | 0 | 63 | |||
|
|||||||
MMH | Ann: MMH - Voting Results of Meeting | 10/12/24 | 0 | 49 | |||
|
|||||||
MMH | Ann: MMH - Annual Meeting Presentation 2024 | 10/12/24 | 0 | 78 | |||
|
|||||||
MMH | Ann: 2024 Notice of Annual Meeting | 12/11/24 | 0 | 78 | |||
|
|||||||
MMH | Ann: Key dates, ASM; Director Nomination | 02/10/24 | 0 | 79 | |||
|
|||||||
MMH | Ann: Marsden Maritime Holdings Announces Results for FY24 | 23/08/24 | 0 | 127 | |||
|
|||||||
MMH | Ann: Interim Profit Announcement HY2024 | 23/02/24 | 0 | 158 | |||
|
|||||||
MMH | Ann: INDEPENDENT DIRECTOR DETERMINATION | 23/11/23 | 0 | 138 | |||
|
See All Discussions